The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial

Andrea J Loizeau, Erika M C D'Agata, Michele L Shaffer, Laura C Hanson, Ruth A Anderson, Timothy Tsai, Daniel A Habtemariam, Elaine H Bergman, Ruth P Carroll, Simon M Cohen, Erin M E Scott, Erin Stevens, Jeremy D Whyman, Elizabeth H Bennert, Susan L Mitchell, Andrea J Loizeau, Erika M C D'Agata, Michele L Shaffer, Laura C Hanson, Ruth A Anderson, Timothy Tsai, Daniel A Habtemariam, Elaine H Bergman, Ruth P Carroll, Simon M Cohen, Erin M E Scott, Erin Stevens, Jeremy D Whyman, Elizabeth H Bennert, Susan L Mitchell

Abstract

Background: Infections are common in nursing home (NH) residents with advanced dementia but are often managed inappropriately. Antimicrobials are extensively prescribed, but frequently with insufficient evidence to support a bacterial infection, promoting the emergence of multidrug-resistant organisms. Moreover, the benefits of antimicrobials remain unclear in these seriously ill residents for whom comfort is often the goal of care. Prior NH infection management interventions evaluated in randomized clinical trials (RCTs) did not consider patient preferences and lack evidence to support their effectiveness in 'real-world' practice.

Methods: This report presents the rationale and methodology of TRAIN-AD (Trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias), a parallel group, cluster RCT evaluating a multicomponent intervention to improve infection management for suspected urinary tract infections (UTIs) and lower respiratory tract infections (LRIs) among NH residents with advanced dementia. TRAIN-AD is being conducted in 28 facilities in the Boston, USA, area randomized in waves using minimization to achieve a balance on key characteristics (N = 14 facilities/arm). The involvement of the facilities includes a 3-month start-up period and a 24-month implementation/data collection phase. Residents are enrolled during the first 12 months of the 24-month implementation period and followed for up to 12 months. Individual consent is waived, thus almost all eligible residents are enrolled (target sample size, N = 410). The intervention integrates infectious disease and palliative care principles and includes provider training delivered through multiple modalities (in-person seminar, online course, management algorithms, and prescribing feedback) and an information booklet for families. Control facilities employ usual care. The primary outcome, abstracted from the residents' charts, is the number of antimicrobial courses prescribed for UTIs and LRIs per person-year alive.

Discussion: TRAIN-AD is the first cluster RCT testing a multicomponent intervention to improve infection management in NH residents with advanced dementia. Its findings will provide an evidence base to support the benefit of a program addressing the critical clinical and public health problem of antimicrobial misuse in these seriously ill residents. Moreover, its hybrid efficacy-effectiveness design will inform the future conduct of cluster RCTs evaluating nonpharmacological interventions in the complex NH setting in a way that is both internally valid and adaptable to the 'real-world'.

Trial registration: ClinicalTrials.gov, NCT03244917 . Registered on 10 August 2017.

Keywords: Antimicrobials; Cluster randomized trial; Decision-making; Dementia; Goals of care; Implementation; Infections; Nursing homes; Palliative care; Pragmatic trial.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Schedule of enrolment, intervention, and assessments. aThe Institutional Review Board waived individual consent and thus almost all eligible residents are enrolled. bThe Trial to Reduce Antimicrobial Use in Nursing Home Residents with Alzheimer’s Disease and other Dementias. cResident assessments include chart reviews done at baseline (2-month look back), every 2 months and death, and each resident is followed for up to 12 months. dBedford Alzheimer Nursing Severity-Subscale (BANS-S: range 7–28, higher scores indicate more functional disability) [32]. eUrinary tract (UTIs) and lower respiratory tract (LRIs) infections. fVital signs (e.g., temperature, respiratory rate), localized signs and symptoms (e.g., cough, hematuria) are recorded 24 h before or 72 h after initial documentation of the suspected infection. gInvestigations include urinalysis and urine, blood cultures, complete blood counts, and chest x-rays. hAny new major acute illnesses other than infections such as bone fracture, stroke, or seizures. iFacility data are collected from three sources: LTCfocus.org website [31]; Medicare.gov website (Medicare NH Compare) [33]; and survey administered to a senior administrator. jMinimum Data Set Cognitive Function Scale (MDS CFS; score = 4 indicates severe impairment) [34]. kNursing Home Compare five-star rating (range 0–5; higher scores indicate better care quality)
Fig. 2
Fig. 2
CONSORT diagram of facilities recruitment, randomization, and resident participation as of 25 July 2019. Anticipated completion of resident enrollment is 11 June 2020. Group A and B represent each trial arm, whose identity remains masked
Fig. 3
Fig. 3
Study timetable of waves of intervention (I) and control (C) nursing home (NH) recruitment
Fig. 4
Fig. 4
Algorithms for managing suspected UTIs and LRIs infections in nursing home residents with advanced dementia. CFU colony-forming units, HR heart rate, LRI lower respiratory tract infection, RR respiratory rate, T temperature, U/A urinalysis, UTI urinary tract infection
Fig. 5
Fig. 5
Proportions of targeted providers completing the training seminar (blue circle) and online course (dotted circle). The Venn diagrams display proportions for all providers (a; N = 341), prescribing providers (physicians, nurse practitioners, and physician assistants) (b; N = 74), and nurses (c; N = 267). The numbers correspond to the 13 facilities which have completed the 3-month start-up period as of 31 July 2019 and exclude those from the remaining facility in which providers are currently offered the training seminar and online course

References

    1. Alzheimer's Association. 2018 Alzheimer's disease facts and figures. . Accessed January 30, 2019.
    1. Mitchell SL. Advanced dementia. N Engl J Med. 2015;372(26):2533–2540. doi: 10.1056/NEJMcp1412652.
    1. Chen J-H, Lamberg JL, Chen Y-C, et al. Occurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia. J Am Geriatr Soc. 2006;54(2):290–295. doi: 10.1111/j.1532-5415.2005.00524.x.
    1. Givens JL, Jones RN, Shaffer ML, Kiely DK, Mitchell SL. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med. 2010;170(13):1102–1107. doi: 10.1001/archinternmed.2010.181.
    1. Mitchell SL, Shaffer ML, Loeb MB, et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med. 2014;174(10):1660–1667. doi: 10.1001/jamainternmed.2014.3918.
    1. Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med. 2009;361(16):1529–1538. doi: 10.1056/NEJMoa0902234.
    1. D'Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med. 2008;168(4):357–362. doi: 10.1001/archinternmed.2007.104.
    1. D'Agata E, Loeb MB, Mitchell SL. Challenges in assessing nursing home residents with advanced dementia for suspected urinary tract infections. J Am Geriatr Soc. 2013;61(1):62–66. doi: 10.1111/jgs.12070.
    1. Mitchell SL, Kiely DK, Hamel MB. Dying with advanced dementia in the nursing home. Arch Intern Med. 2004;164(3):321–326. doi: 10.1001/archinte.164.3.321.
    1. Mitchell SL, Black BS, Ersek M, et al. Advanced dementia: state of the art and priorities for the next decade. Ann Intern Med. 2012;156(1):45–51. doi: 10.7326/0003-4819-156-1-201201030-00008.
    1. Mehr DR, van der Steen JT, Kruse RL, Ooms ME, Rantz M, Ribbe MW. Lower respiratory infections in nursing home residents with dementia: a table of two countries. Gerontologist. 2003;43(2):85–93. doi: 10.1093/geront/43.suppl_2.85.
    1. Loeb M, Brazil K, Lohfeld L, et al. Optimizing antibiotics in residents of nursing homes: protocol of a randomized trial. BMC Health Serv Res. 2015;2(17):1–6.
    1. Mody L. Optimizing antimicrobial use in nursing homes: no longer optional. J Am Geriatr Soc. 2007;55(8):1301–1302. doi: 10.1111/j.1532-5415.2007.01253.x.
    1. Tenney J, Hudson N, Alnifaidy H, Cheung Li JT, Fung KH. Risk factors for multidrug-resistant organisms in urinary tract infections: a systematic literature review. Saudi Pharm J. 2018;26(5):678–684. doi: 10.1016/j.jsps.2018.02.023.
    1. Loeb MB, Craven S, McGeer AJ, et al. Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol. 2003;157(1):40–47. doi: 10.1093/aje/kwf173.
    1. Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D'Agata EMC. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc. 2008;56(7):1276–1280. doi: 10.1111/j.1532-5415.2008.01787.x.
    1. Dufour AB, Shaffer ML, D'Agata EMC, Habtemariam D, Mitchell SL. Survival after suspected urinary tract infection in individuals with advanced dementia. J Am Geriatr Soc. 2015;63(12):2472–2477. doi: 10.1111/jgs.13833.
    1. Morrison RS, Ahronheim JC, Morrison GR, et al. Pain and discomfort associated with common hospital procedures and experiences. J Pain Symptom Manag. 1998;15(2):91–101. doi: 10.1016/S0885-3924(97)00261-3.
    1. Givens JL, Selby K, Goldfeld KS, Mitchell SL. Hospital transfers of nursing home residents with advanced dementia. J Am Geriatr Soc. 2012;60(5):905–909. doi: 10.1111/j.1532-5415.2012.03919.x.
    1. Mitchell SL, Palmer JA, Volandes AE, Hanson LC, Habtemariam D, Shaffer ML. Level of care preferences among nursing home residents with advanced dementia. J Pain Symptom Manag. 2017;54(3):340–345. doi: 10.1016/j.jpainsymman.2017.04.020.
    1. Mody L, Krein SL, Saint SK, et al. A targeted infection prevention intervention in nursing home residents with indwelling devices. JAMA Intern Med. 2015;175(5):714–719. doi: 10.1001/jamainternmed.2015.132.
    1. Loed M, Carusone SC, Goeree R, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia. JAMA. 2006;295(21):2503–2510. doi: 10.1001/jama.295.21.2503.
    1. Loeb M, Brazil K, Lohfeld L, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ. 2005;331(7518):669–675. doi: 10.1136/bmj.38602.586343.55.
    1. Monette J, Miller MA, Monette M, et al. Effect of an educational intervention on optimizing antibiotic prescribing in long-term care facilities. J Am Geriatr Soc. 2007;55(8):1231–1235. doi: 10.1111/j.1532-5415.2007.01250.x.
    1. Naughton BJ, Mylotte JM, Ramadan F, Karuza J, Priore RL. Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia. J Am Geriatr Soc. 2001;49(8):1020–1024. doi: 10.1046/j.1532-5415.2001.49203.x.
    1. Hutt E, Ruscin JM, Corbett K, et al. A multifaceted intervention to implement guidelines improved treatment of nursing home-acquired pneumonia in a state veterans home. J Am Geriatr Soc. 2006;54(11):1694–1700. doi: 10.1111/j.1532-5415.2006.00937.x.
    1. Zimmerman S, Mitchell MC, Beeber AS, et al. Strategies to reduce potentially inappropriate antibiotic prescribing in assisted living and nursing homes and inform other quality improvement efforts. Am J Med Res. 2015;2(1):41–52.
    1. Zimmerman S, Sloane PD, Bertrand R, et al. Successfully reducing antibiotic prescribing in nursing homes. J Am Geriatr Soc. 2014;62(5):907–912. doi: 10.1111/jgs.12784.
    1. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350(1):h2147–h2111. doi: 10.1136/bmj.h2147.
    1. Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M. Reenvisioning clinical science: unifying the discipline to improve the public health. Clin Psychol Sci. 2014;2(1):22–34. doi: 10.1177/2167702613497932.
    1. Brown University. Long-term care (LTCfocus): facts on care in the US. LTCfocus. . Accessed January 30, 2019.
    1. Volicer L, Hurley AC, Lathi DC, Kowall NW. Measurement of severity in advanced Alzheimer's disease. J Gerontol. 2008;49(5):M223–M226. doi: 10.1093/geronj/49.5.M223.
    1. U.S. Centers for Medicare Medicaid Services. Nursing Home Compare: the official U.S government site for medicare. NHC. . Accessed January 30, 2019.
    1. Thomas KS, Dosa D, Wysocki A, Mor V. The minimum data set 3.0 cognitive function scale. Med Care. 2017;55(9):e68–e72. doi: 10.1097/MLR.0000000000000334.
    1. Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005;330(7495):843. doi: 10.1136/bmj.330.7495.843.
    1. Ivers NM, Halperin IJ, Barnsley J, et al. Allocation techniques for balance at baseline in cluster randomized trials: a methodological review. Trials. 2012;13(120):1–9.
    1. Mitchell SL, Shaffer ML, Cohen S, Hanson LC, Habtemariam D, Volandes AE. An advance care planning video decision support tool for nursing home residents with advanced dementia. JAMA Intern Med. 2018;178(7):961–969. doi: 10.1001/jamainternmed.2018.1506.
    1. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–1139. doi: 10.1176/ajp.139.9.1136.
    1. Back A, Arnold R, Edwards K, Tulsky J. VITALtalk. . Accessed January 30, 2019.
    1. Loeb M, Bentley DW, Bradley S, et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol. 2001;22(2):120–124. doi: 10.1086/501875.
    1. Mitchell SL, Shaffer ML, Kiely DK, Givens JL, D'Agata E. The study of pathogen resistance and antimicrobial use in dementia: study design and methodology. Arch Gerontol Geriatr. 2013;56(1):16–22. doi: 10.1016/j.archger.2012.08.001.
    1. Harvard Medical School Department of Continuing Education. Management of infections in advanced dementia. . Accessed January 30, 2019.
    1. Centers for Medicare Medicaid Services. Quality assurance (QA) and performance improvement (PI). . Accessed January 30, 2019.
    1. Rutterford C, Copas A, Eldridge S. Methods for sample size determination in cluster randomized trials. Int J Epidemiol. 2015;44(3):1051–1067. doi: 10.1093/ije/dyv113.
    1. Cameron AC, Gelbach JB, Miller DL. Bootstrap-based improvements for inference with clustered errors. Rev Econ Stat. 2008;90(3):414–427. doi: 10.1162/rest.90.3.414.
    1. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94(446):496–509. doi: 10.1080/01621459.1999.10474144.
    1. Centers for Disease Control and Prevention. The core elements of antibiotic stewardship for nursing homes. . Accessed January 30, 2019.
    1. Crnich CJ, Jump R, Trautner B, Sloane PD, Mody L. Optimizing antibiotic stewardship in nursing homes: a narrative review and recommendations for improvement. Drugs Aging. 2015;32(9):699–716. doi: 10.1007/s40266-015-0292-7.
    1. Juthani-Mehta M, Malani PN, Mitchell SL. Antimicrobials at the end of life: an opportunity to improve palliative care and infection management. JAMA. 2015;314(19):2017–2018. doi: 10.1001/jama.2015.13080.
    1. Meeker D, Linder JA, Fox CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices. JAMA. 2016;315(6):562–569. doi: 10.1001/jama.2016.0275.
    1. Trautner BW, Grigoryan L, Petersen NJ, et al. Effectiveness of an antimicrobial stewardship approach for urinary catheter-associated asymptomatic bacteriuria. JAMA Intern Med. 2015;175(7):1120–1128. doi: 10.1001/jamainternmed.2015.1878.
    1. Anderson RA, Issel ML, McDaniel RR. Nursing homes as complex adaptive systems: relationship between management practice and resident outcomes. Nurs Res. 2003;52(1):12–21. doi: 10.1097/00006199-200301000-00003.
    1. Rantz MJ, Flesner MK, Zwygart-Stauffacher M. Improving care in nursing homes using quality measures/indicators and complexity science. J Nurs Care Qual. 2010;25(1):5–12. doi: 10.1097/NCQ.0b013e3181c12b0f.
    1. The U.S. Department of Health & Human Services. The Secretary’s Advisory Committee on Human Research Protections recommendations attachment D: informed consent and waiver of consent. . Accessed July 26, 2019.
    1. Dal-Ré R, Avendaño-Solà C, Bloechl-Daum B, et al. Low risk pragmatic trials do not always require participants’ informed consent. BMJ. 2019;364:l1092. doi: 10.1136/bmj.l1092.

Source: PubMed

3
購読する